Kieran Murphy

President and CEO at GE Healthcare Life Sciences.

Kieran Murphy is President and Chief Executive Officer of GE Healthcare Life Sciences, a $3.7 billion molecular medicine business that provides a broad range of industry- leading technologies and services for drug discovery, pre-clinical and clinical development and biopharmaceutical manufacturing, as well as molecular tools for therapy selection and treatment monitoring in patient care. Kieran was appointed CEO in May 2013, following a strategic decision to combine the product and technical capabilities of two former GE Healthcare units, Life Sciences and Medical Diagnostics.

Kieran joined GE Healthcare in 2008 from Whatman plc, a $230 million global supplier of filters and membranes for laboratory research, life sciences and medical diagnostic applications. Kieran has over twenty years’ experience in the global life sciences and biotechnology industry, beginning his career with Janssen Pharmaceutical, a division of Johnson and Johnson, followed by leadership roles with Mallinckrodt, veterinary medicines provider Vericore, Novartis, Adprotech, ML Laboratories and Innovata plc.

Kieran earned his bachelor’s degree in 1984 from University College, Dublin. He subsequently graduated from the University of Manchester Institute of Science and Technology with a master’s degree in Marketing.

Other team Members

Professor Nabeel Affara

View profile

Dr Cecilia Tsui


View profile

Beatrice Volpe

View profile

Professor Shai Vyakarnam

View profile

Cristina Gimenez Vives

Global Coordinator IMAGINE IF!

View profile
We use cookies to ensure that we give you the best tailored experience on our website based on your preferences. By continuing to use our services, you are giving us your consent to use cookies. Learn more here.